The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS. Issue 11 (2nd October 2018) - Alkharabsheh, Omar; Al‐Kali, Aref; Saadeh, Salwa; He, Rong; Viswanatha, David; Greipp, Patricia; Reichard, Kaaren; Shah, Mithun; Gangat, Naseema; Patnaik, Mrinal; Hogan, William; Litzow, Mark; et al.